Advertisement

Topics

Global and Regional Artificial Urinary Sphincter Implantation Device Market Research Report 2017 [Report Updated: 27102017] Prices from USD $3500

12:38 EST 9 Nov 2017 | BioPortfolio Reports

Summary

Artificial Urinary Sphincter Implantation Device in this report refers to artificial urinary sphincter AUS.

Market Segment as follows:

By Region

AsiaPacific

North America

Europe

South America

Middle East Africa

By Type

AMS 800

Others

By Application

Man

Woman

By Company

Boston Scientific Corporation

ZEPHYR Surgical Implants

RBMMed

Silimed

GT Urological

The main contents of the report including:

Section 1:

Product definition, type and application, global and regional market overview;

Section 2:

Global and regional Market competition by company;

Section 3:

Global and regional sales revenue, volume and price by type;

Section 4:

Global and regional sales revenue, volume and price by application;

Section 5:

Regional export and import;

Section 6:

Company information, business overview, sales data and product specifications;

Section 7:

Industry chain and raw materials;

Section 8:

SWOT and Porter's Five Forces;

Section 9:

Conclusion.

Original Article: Global and Regional Artificial Urinary Sphincter Implantation Device Market Research Report 2017 [Report Updated: 27102017] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Global and Regional Artificial Urinary Sphincter Implantation Device Market Research Report 2017 [Report Updated: 27102017] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...